최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기Journal of microbiology and biotechnology, v.16 no.10, 2006년, pp.1491 - 1498
Song, Ho-Chun (Department of Nuclear Medicine, Chonnam National University Hospital) , Na, Kun (Division of Biotechnology, The Catholic University of Korea) , Park, Keun-Hong (College of Medicine, Pochon CHA University, Cell and Gene Therapy Research Institute) , Shin, Chan-Ho (Department of Nuclear Medicine, Chonnam National University Hospital) , Bom, Hee-Seung (Department of Nuclear Medicine, Chonnam National University Hospital) , Kang, Dong-Min (Korea Basic Science Institute, Chuncheon Center) , Kim, Sung-Won (Biomedical Research Center, Korea Institute of Science and Technology) , Lee, Eun-Seong (Department of Pharmaceutics and Pharmaceutical Chemistry, University of Utah) , Lee, Don-Haeng (Department of Internal Medicine, Inha University)
The feasibility of pullulan acetate nanoparticles (PAN) with ionic strength (IS) sensitivity as a radioisotope carrier to inhibit tumor growth is demonstrated. PAN was radiolabeled with rhenium 188 (Re-188) without any chelating agents. The labeling efficiency of Re-188 into PAN (Re-188PAN) was 주제어
* AI 자동 식별 결과로 적합하지 않은 문장이 있을 수 있으니, 이용에 유의하시기 바랍니다.
Blower, P. J., A. S. Lam, M. J. O'Doherty, A. G. Kettle, A. J. Coakley, and F. F Jr. Knapp. 1998. Pentavalent rhenium-188 dimercaptosuccinic acid for targeted radiotherapy: Synthesis and preliminary animal and human studies. Eur. J. Nucl. Med. 25: 613-621
Cammas, S., K. Suzuki, C. Sone, Y. Sakurai, K. Kataoka, and T. Okano. 1997. Thermo-responsive polymer nanoparticles with a core-shell micelle structure as site specific drug carriers. J. Control. Release 48: 157-164
Chung, J. E., M. Yokoyama, and T. Okano. 2000. Inner core segment design for delivery control of thermo-responsive polymeric micelles. J. Control. Release 65: 93-103
Crudo, J. L., M. M. Edreira, E. R. Obenaus, M. Chinol, G. Paganelli, and S. G. de Castiglia. 2002. Optimization of antibody labeling with rhenium-188 using a prelabeled $MAG_3$ chelate. Int. J. Pharm. 248: 173-182
Deutsch, E., K. Libson, J. L. Vanderheyden, A. R. Ketring, and H. R. Maxon. 1986. The chemistry of rhenium and technetium as related to use of isotope of these elements in therapeutic and diagnostic nuclear medicine. Int. J. Radiat. Appl. Instrum. B 13: 465-477
El-Mabhouh, A. and J. R. Mercer. 2005. 188Re-labeled bisphosphonates as potential bifunctional agents for therapy in patients with bone metastases. Appl. Radiat. Isot. 62: 541-549
Friesen, C., A. Lubatschofski, J. Kotzerke, I. Buchmann, S. N. Reske, and K. M. Debatin. 2003. Beta-irradiation used for systemic radioimmunotherapy induces apoptosis and activates apoptosis pathways in leukaemia cells. Eur. J. Nucl. Med. Mol. Imaging 30: 1251-1261
Jeong, J. M., Y. J. Lee, Y. J. Kim, Y. S. Chang, D. S. Lee, J. K. Chung, et al. 2000. Preparation of rhenium-188-tin colloid as a radiation synovectomy agent and comparison with rhenium-188-sulfur colloid. Appl. Radiat. Isot. 52: 851-855
Juweid, M., R. M. Sharkey, L. C. Swayne, G. L. Griffiths, R. Dunn, and D. M. Goldenberg. 1998. Pharmacokinetics, dosimetry and toxicity of rhenium-188-labeled anti-carcinoembryonic antigen monoclonal antibody, MN-14, in gastrointestinal cancer. J. Nucl. Med. 39: 34-42
Knapp, F. F Jr., A. L. Beets, S. Guhlke, P. O. Zamora, H. Bender, and H. Palmedo. 1997. Availability of rhenium-188 from the alumina-based tungsten-188/rhenium-188 generator for preparation of rhenium-188-labeled radiopharmaceuticals for cancer treatment. Anticancer Res. 17: 1783-1795
Lee, J. D., W. I. Yang, M. G. Lee, Y. H. Ryu, J. H. Park, K. H. Shin, et al. 2002. Effective local control of malignant melanoma by intratumoural injection of a beta-emitting radionuclide. Eur. J. Nucl. Med. Mol. Imaging 29: 221-230
Lee, E. S., K. Na, and Y. H. Bae. 2003. Polymeric micelle for tumor pH and folate mediated targeting. J. Control. Release 91: 103-113
Lee, I. and Y. H. Lee. 1999. The effect of various therapeutic solutions including colloidal chromic $^{32}P$ via an intratumoral injection on the tumor physiological parameters of AsPC-1 human pancreatic tumor xenografts in nude mice. Clin. Cancer Res. 5: 3139-3142
Liepe, K., J. Kropp, R. Runge, and J. Kotzerke. 2003. Therapeutic efficiency of rhenium-188-HEDP in human prostate cancer skeletal metastases. Br. J. Cancer 89: 625-629
Lin, W. Y., S. C. Tsai, J. F. Hsieh, and S. J. Wang. 2000. Effects of $^{90}Y$ -microspheres on liver tumors: Comparison of intratumoral injection method and intra-arterial injection method. J. Nucl. Med. 41: 1892-1897
Na, K., E. S. Lee, and Y. H. Bae. 2003. Adriamycin loaded pullulan acetate/sulfonamide conjugate nanoparticles responding to tumor pH: pH-dependent cell interaction, internalization and cytotoxicity in vitro. J. Control. Release 87: 3-13
Na, K., K. H. Lee, and Y. H. Bae. 2004. pH-Sensitivity and pH-dependent interior structure change of self-assembled hydrogel nanoparticles of pullulan acetate/oligo(methacryloyl sulfadimethoxine) (PA/OSDM) conjugates. J. Control. Release 97: 513-525
Na, K., T. B. Lee, K.-H. Park, E.-K. Shin, and H.-K. Choi. 2003. Self-assembled nanoparticles of hydrophobically-modified polysaccharide bearing vitamin H as a targeted anti-cancer drug delivery system. Eur. J. Pharm. Sci. 18: 165-173
Na, K. and Y. H. Bae. 2002. Self-assembled hydrogel nanoparticles responsive to tumor extracelluar pH from hydrophobized pullulan and sulfonamide conjugate; Characterization, aggregation and adriamycin release in vitro. Pharm. Res. 19: 681-688
Nakajo. M., H. Kobayashi, K. Shimabukuro, K. Shirono, H. Sakata, and M. Taguchi. 1988. Biodistribution and in vivo kinetics of iodine-131 lipiodol infused via the hepatic artery of patients with hepatic cancer. J. Nucl. Med. 29: 1066-1077
Palmedo, H., S. Guhlke, H. Bender, J. Sartor, G. Schoeneich, and J. Risse. 2000. Dose escalation study with rhenium-188 hydroxyethylidene diphosphonate in prostate cancer patients with osseous metastases. Eur. J. Nucl. Med. 27: 123-130
Reske, S. N., D. Bunjes, I. Buchmann, U. Seitz, G. Glatting, B. Neumaier, et al. 2001. Targeted bone marrow irradiation in the conditioning of high-risk leukaemia prior to stem cell transplantation. Eur. J. Nucl. Med. 28: 807-815
Seong, S. K., J. M. Ryu, D. H. Shin, E. J. Bae, A. Shigematsu, Y. Hatori, J. Nishigaki, C. Kwak, S. E. Lee, and K. B. Park. 2005. Biodistribution and excretion of radioactivity after the administration of 166Ho-chitosan complex (DW-166HC) into the prostate of rat. Eur. J. Nucl. Med. Mol. Imaging 32: 910-917
Suzuki, Y. S., Y. Momose, N. Higashi, A. Shigematsu, K. B. Park, Y. M. Kim, J. R. Kim, and J. M. Ryu. 1998. Biodistribution and kinetics of holmium-166-chitosan complex (DW-166HC) in rats and mice. J. Nucl. Med. 39: 2161-2166
Tian, J. H., B. X. Xu, J. M. Zhang, B. W. Dong, P. Liang, and X. D. Wang. 1996. Ultrasound-guided internal radiotherapy using yttrium-90-glass microspheres for liver malignancies. J. Nucl. Med. 37: 958-963
Tomayko, M. M. and C. P. Reynolds. 1989. Determination of subcutaneous tumor size in athymic (nude) mice. Cancer Chemother. Pharmacol. 24: 148-154
Wang, S. J., W. Y. Lin, M. N. Chen, C. S. Chi, J. T. Chen, and W. L. Ho. 1998. Intratumoral injection of rhenium-188 microspheres into an animal model of hepatoma. J. Nucl. Med. 39: 1752-1757
Yuen, S. 1974. Pullulan and its applications. Process Biochem. 9: 7-22
Zweit, J. 1996. Radionuclides and carrier molecules for therapy. Phys. Med. Biol. 41: 1905-1914
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.